241810
Perceived colonoscopy barriers and facilitators among urban African American patients and their medical residents
Monday, October 31, 2011: 4:45 PM
Sarah Bauerle Bass, PhD, MPH
,
Department of Public Health, Temple University, Philadelphia, PA
Michael J. Rovito, PhD
,
Department of Public Health, Temple University, Philadelphia, PA
Stephanie Ward, MD, MPH
,
General Internal Medicine, Temple University, Philadelphia, PA
Thomas F. Gordon, PhD
,
Department of Public Health, Temple University, Philadelphia, PA
Anu Paranjape, MD, MPH
,
General Internal Medicine, Temple University, Philadelphia, PA
Karen Lin, MD, MPH
,
General Internal Medicine, Temple University, Philadelphia, PA
Brian Meyer, MD, MPH
,
General Internal Medicine, Temple University, Philadelphia, PA
Lalitha Parameswaran
,
Public Health, Temple University Center for Asian Health, Philadelphia, PA
Caitlin Wolak, MPH
,
Department of Public Health, Temple University, Philadelphia, PA
Johnson Britto, MD, MPH
,
Department of Public Health, Temple University, Philadelphia, PA
Sheryl Burt Ruzek, PhD, MPH
,
Department of Public Health, Temple University, Philadelphia, PA
African Americans suffer from higher colorectal cancer (CRC) morbidity and mortality than whites, yet have the lowest screening rates. To understand barriers and facilitators to CRC screening, we used perceptual mapping (multidimensional scaling) methods to compare patients' perceptions of colonoscopy and general preventive health practices to those of their doctors in a general internal medicine clinic in a large urban hospital in Philadelphia. African American patients (n=102) were surveyed about their own CRC screening beliefs; third-year resident physicians (n=29) were asked what they perceived their patients believed. The perceptual maps showed significant differences between the patients' and physicians' perceptions of barriers, facilitators, and beliefs about CRC screening. Physicians believed logistical lifestyle issues were the greatest screening barriers for their patients whereas fears of complications, pain, and a possible cancer diagnosis were the most important barriers perceived by patients. Physicians also underestimated patients' understanding of the benefits and importance of screening, doctors' recommendations, and beliefs that faith in God could facilitate CRC screening. Both physicians and patients perceived a doctor's recommendation for screening was an important facilitator. Better understanding of patient perceptions can be used to improve doctor-patient communication about CRC screening, and to improve medical resident training by incorporating specific messages tailored for use with African American patients.
Learning Areas:
Communication and informatics
Other professions or practice related to public health
Planning of health education strategies, interventions, and programs
Public health or related research
Social and behavioral sciences
Learning Objectives: 1. Discuss the perceived barriers and facilitators to colorectal cancer screening for urban African Americans.
2. Identify how internal medicine resident physicians perceive their patients’ barriers and facilitators to colorectal cancer screening.
3. Explain how better understanding of patients’ and physicians’ perceptions about colorectal cancer screening can lead to improved doctor-patient communication and medical resident training by informing message tailoring for African American patients.
Keywords: Health Communications, Cancer
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I am qualified to present because I was responsible for the analysis and interpretation of the data for this study. As a PhD candidate who specializes in health communication, I have been responsible for implementing disease prevention and treatment programs as well as developing tailored health communication materials for diverse groups and health issues since 2004.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|